Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

259 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
In vivo effects of recombinant-interferon-beta1b treatment on polymorphonuclear cell and monocyte functions and on T-cell-mediated antibacterial activity in patients with relapsing-remitting multiple sclerosis.
Maffione AB, Tatò E, Losito S, Nacci C, Mitolo V, Troiano M, Ruggieri M, Livrea P, Jirillo E. Maffione AB, et al. Among authors: livrea p. Immunopharmacol Immunotoxicol. 2000 Feb;22(1):1-18. doi: 10.3109/08923970009016402. Immunopharmacol Immunotoxicol. 2000. PMID: 10737253 Clinical Trial.
Glatiramer acetate in multiple sclerosis: a review.
Ruggieri M, Avolio C, Livrea P, Trojano M. Ruggieri M, et al. Among authors: livrea p. CNS Drug Rev. 2007 Summer;13(2):178-91. doi: 10.1111/j.1527-3458.2007.00010.x. CNS Drug Rev. 2007. PMID: 17627671 Free PMC article. Review.
Voltage-gated sodium channel blockers as immunomodulators.
Roselli F, Livrea P, Jirillo E. Roselli F, et al. Among authors: livrea p. Recent Pat CNS Drug Discov. 2006 Jan;1(1):83-91. doi: 10.2174/157488906775245255. Recent Pat CNS Drug Discov. 2006. PMID: 18221194 Review.
Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in multiple sclerosis: relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatment.
Avolio C, Filippi M, Tortorella C, Rocca MA, Ruggieri M, Agosta F, Tomassini V, Pozzilli C, Stecchi S, Giaquinto P, Livrea P, Trojano M. Avolio C, et al. Among authors: livrea p. Mult Scler. 2005 Aug;11(4):441-6. doi: 10.1191/1352458505ms1193oa. Mult Scler. 2005. PMID: 16042227 Clinical Trial.
259 results